Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007
<p>Abstract</p> <p>Background</p> <p>Although factors associated with the utilisation of bone density measurement (BDM) and osteoporosis treatment have been regularly assessed in the US and Canada, they have not been effectively analysed in European countries. This stud...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2474/14/10 |
id |
doaj-0d9df2322f5a42d6b53873d2fdfd5450 |
---|---|
record_format |
Article |
spelling |
doaj-0d9df2322f5a42d6b53873d2fdfd54502020-11-24T21:04:43ZengBMCBMC Musculoskeletal Disorders1471-24742013-01-011411010.1186/1471-2474-14-10Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007Born RitaZwahlen Marcel<p>Abstract</p> <p>Background</p> <p>Although factors associated with the utilisation of bone density measurement (BDM) and osteoporosis treatment have been regularly assessed in the US and Canada, they have not been effectively analysed in European countries. This study assessed factors associated with the utilisation of BDM and osteoporosis medication (OM) in Switzerland.</p> <p>Methods</p> <p>The Swiss Health Survey 2007 data included self-reported information on BDM and OM for women aged 40 years and older who were living in private households. Multivariable logistic regression analysis was used to identify sociodemographic, socioeconomic, healthcare-related and osteoporosis risk factors associated with BDM and OM utilisation.</p> <p>Results</p> <p>The lifetime prevalence of BDM was 25.6% (95% CI: 24.3-26.9%) for women aged 40 years and older. BDM utilisation was associated with most sociodemographic factors, all the socioeconomic and healthcare-related factors, and with major osteoporosis risk factors analysed. The prevalence of current OM was 7.8% (95% CI: 7.0-8.6%) and it was associated with some sociodemographic and most healthcare-related factors but only with one socioeconomic factor.</p> <p>Conclusions</p> <p>In Swiss women, ever having had a BDM and current OM were low and utilisation disparities exist according to sociodemographic, socioeconomic and healthcare-related factors. This might foster further health inequalities. The reasons for these findings should be addressed in further studies of the elderly women, including those living in institutions.</p> http://www.biomedcentral.com/1471-2474/14/10Bone density measurementOsteoporosisMedicationSociodemographicSocioeconomicHealth survey |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Born Rita Zwahlen Marcel |
spellingShingle |
Born Rita Zwahlen Marcel Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007 BMC Musculoskeletal Disorders Bone density measurement Osteoporosis Medication Sociodemographic Socioeconomic Health survey |
author_facet |
Born Rita Zwahlen Marcel |
author_sort |
Born Rita |
title |
Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007 |
title_short |
Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007 |
title_full |
Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007 |
title_fullStr |
Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007 |
title_full_unstemmed |
Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss Health Survey 2007 |
title_sort |
disparities in bone density measurement history and osteoporosis medication utilisation in swiss women: results from the swiss health survey 2007 |
publisher |
BMC |
series |
BMC Musculoskeletal Disorders |
issn |
1471-2474 |
publishDate |
2013-01-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Although factors associated with the utilisation of bone density measurement (BDM) and osteoporosis treatment have been regularly assessed in the US and Canada, they have not been effectively analysed in European countries. This study assessed factors associated with the utilisation of BDM and osteoporosis medication (OM) in Switzerland.</p> <p>Methods</p> <p>The Swiss Health Survey 2007 data included self-reported information on BDM and OM for women aged 40 years and older who were living in private households. Multivariable logistic regression analysis was used to identify sociodemographic, socioeconomic, healthcare-related and osteoporosis risk factors associated with BDM and OM utilisation.</p> <p>Results</p> <p>The lifetime prevalence of BDM was 25.6% (95% CI: 24.3-26.9%) for women aged 40 years and older. BDM utilisation was associated with most sociodemographic factors, all the socioeconomic and healthcare-related factors, and with major osteoporosis risk factors analysed. The prevalence of current OM was 7.8% (95% CI: 7.0-8.6%) and it was associated with some sociodemographic and most healthcare-related factors but only with one socioeconomic factor.</p> <p>Conclusions</p> <p>In Swiss women, ever having had a BDM and current OM were low and utilisation disparities exist according to sociodemographic, socioeconomic and healthcare-related factors. This might foster further health inequalities. The reasons for these findings should be addressed in further studies of the elderly women, including those living in institutions.</p> |
topic |
Bone density measurement Osteoporosis Medication Sociodemographic Socioeconomic Health survey |
url |
http://www.biomedcentral.com/1471-2474/14/10 |
work_keys_str_mv |
AT bornrita disparitiesinbonedensitymeasurementhistoryandosteoporosismedicationutilisationinswisswomenresultsfromtheswisshealthsurvey2007 AT zwahlenmarcel disparitiesinbonedensitymeasurementhistoryandosteoporosismedicationutilisationinswisswomenresultsfromtheswisshealthsurvey2007 |
_version_ |
1716770057016573952 |